
James M. Hewitt
Examiner (ID: 13022, Phone: (571)272-7084 , Office: P/3679 )
| Most Active Art Unit | 3679 |
| Art Unit(s) | 3679, 3628 |
| Total Applications | 1889 |
| Issued Applications | 1303 |
| Pending Applications | 154 |
| Abandoned Applications | 447 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5875276
[patent_doc_number] => 20060166972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator'
[patent_app_type] => utility
[patent_app_number] => 10/564029
[patent_app_country] => US
[patent_app_date] => 2004-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8196
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166972.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564029
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564029 | Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator | Jul 6, 2004 | Abandoned |
Array
(
[id] => 6983921
[patent_doc_number] => 20050153991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Methods of treatment of chronic lymphocytic leukemia using roscovitine'
[patent_app_type] => utility
[patent_app_number] => 10/881869
[patent_app_country] => US
[patent_app_date] => 2004-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 14048
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153991.pdf
[firstpage_image] =>[orig_patent_app_number] => 10881869
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/881869 | Methods of treatment of chronic lymphocytic leukemia using roscovitine | Jun 29, 2004 | Abandoned |
Array
(
[id] => 7276505
[patent_doc_number] => 20040235956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders'
[patent_app_type] => new
[patent_app_number] => 10/879814
[patent_app_country] => US
[patent_app_date] => 2004-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15568
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235956.pdf
[firstpage_image] =>[orig_patent_app_number] => 10879814
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/879814 | Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders | Jun 27, 2004 | Abandoned |
Array
(
[id] => 7352308
[patent_doc_number] => 20040248971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Use of vitamin e succinate and antiandrogen combination'
[patent_app_type] => new
[patent_app_number] => 10/484785
[patent_app_country] => US
[patent_app_date] => 2004-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 10580
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248971.pdf
[firstpage_image] =>[orig_patent_app_number] => 10484785
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/484785 | Use of vitamin e succinate and antiandrogen combination | Jun 6, 2004 | Abandoned |
Array
(
[id] => 7026688
[patent_doc_number] => 20050020558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics'
[patent_app_type] => utility
[patent_app_number] => 10/856742
[patent_app_country] => US
[patent_app_date] => 2004-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9414
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20050020558.pdf
[firstpage_image] =>[orig_patent_app_number] => 10856742
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/856742 | Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics | May 26, 2004 | Issued |
Array
(
[id] => 7026687
[patent_doc_number] => 20050020557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/856696
[patent_app_country] => US
[patent_app_date] => 2004-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6693
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20050020557.pdf
[firstpage_image] =>[orig_patent_app_number] => 10856696
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/856696 | Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors | May 26, 2004 | Abandoned |
Array
(
[id] => 7026620
[patent_doc_number] => 20050020534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Method for treating diseases using HSP90-inhibiting agents in combination with antimetabolites'
[patent_app_type] => utility
[patent_app_number] => 10/856342
[patent_app_country] => US
[patent_app_date] => 2004-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7027
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20050020534.pdf
[firstpage_image] =>[orig_patent_app_number] => 10856342
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/856342 | Method for treating diseases using HSP90-inhibiting agents in combination with antimetabolites | May 26, 2004 | Abandoned |
Array
(
[id] => 7216229
[patent_doc_number] => 20050054625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Method for treating diseases using HSP90-inhibiting agents in combination with nuclear export inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/856703
[patent_app_country] => US
[patent_app_date] => 2004-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6461
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054625.pdf
[firstpage_image] =>[orig_patent_app_number] => 10856703
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/856703 | Method for treating diseases using HSP90-inhibiting agents in combination with nuclear export inhibitors | May 26, 2004 | Abandoned |
Array
(
[id] => 7156050
[patent_doc_number] => 20050026893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Method for treating diseases using HSP90-inhibiting agents in combination with immunosuppressants'
[patent_app_type] => utility
[patent_app_number] => 10/857166
[patent_app_country] => US
[patent_app_date] => 2004-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6241
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026893.pdf
[firstpage_image] =>[orig_patent_app_number] => 10857166
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/857166 | Method for treating diseases using HSP90-inhibiting agents in combination with immunosuppressants | May 26, 2004 | Abandoned |
Array
(
[id] => 7026685
[patent_doc_number] => 20050020556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes'
[patent_app_type] => utility
[patent_app_number] => 10/856344
[patent_app_country] => US
[patent_app_date] => 2004-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7309
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20050020556.pdf
[firstpage_image] =>[orig_patent_app_number] => 10856344
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/856344 | Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes | May 26, 2004 | Abandoned |
Array
(
[id] => 7215807
[patent_doc_number] => 20050054589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Method for treating diseases using HSP90-inhibiting agents in combination with antibiotics'
[patent_app_type] => utility
[patent_app_number] => 10/857605
[patent_app_country] => US
[patent_app_date] => 2004-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8430
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054589.pdf
[firstpage_image] =>[orig_patent_app_number] => 10857605
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/857605 | Method for treating diseases using HSP90-inhibiting agents in combination with antibiotics | May 26, 2004 | Abandoned |
Array
(
[id] => 7249608
[patent_doc_number] => 20040258692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Method for the treatment of cardiotoxicity induced by antitumor compounds'
[patent_app_type] => new
[patent_app_number] => 10/495836
[patent_app_country] => US
[patent_app_date] => 2004-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3126
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20040258692.pdf
[firstpage_image] =>[orig_patent_app_number] => 10495836
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/495836 | Method for the treatment of cardiotoxicity induced by antitumor compounds | May 16, 2004 | Abandoned |
Array
(
[id] => 7347512
[patent_doc_number] => 20040192751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Amino acid composition for ameliorating liver failure'
[patent_app_type] => new
[patent_app_number] => 10/471850
[patent_app_country] => US
[patent_app_date] => 2004-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5239
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192751.pdf
[firstpage_image] =>[orig_patent_app_number] => 10471850
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/471850 | Amino acid composition for ameliorating liver failure | May 13, 2004 | Abandoned |
Array
(
[id] => 7257370
[patent_doc_number] => 20040259959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Method and pharmaceutical preparation for reducing the activity of cells'
[patent_app_type] => new
[patent_app_number] => 10/495213
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2864
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259959.pdf
[firstpage_image] =>[orig_patent_app_number] => 10495213
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/495213 | Method and pharmaceutical preparation for reducing the activity of cells | May 11, 2004 | Abandoned |
Array
(
[id] => 7075262
[patent_doc_number] => 20050148530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 10/831620
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 87507
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148530.pdf
[firstpage_image] =>[orig_patent_app_number] => 10831620
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/831620 | RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) | Apr 22, 2004 | Abandoned |
Array
(
[id] => 5705835
[patent_doc_number] => 20060194883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Mmp expression inhibitor'
[patent_app_type] => utility
[patent_app_number] => 10/553434
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3260
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194883.pdf
[firstpage_image] =>[orig_patent_app_number] => 10553434
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/553434 | Mmp expression inhibitor | Apr 22, 2004 | Abandoned |
Array
(
[id] => 5889974
[patent_doc_number] => 20060276460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Use of piperazine phenothiazine derivatives in the manufacture of a medicament with neuroprotector and/or neurotrophic effects on cns and/or pns'
[patent_app_type] => utility
[patent_app_number] => 10/551395
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2877
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276460.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551395
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551395 | Use of piperazine phenothiazine derivatives in the manufacture of a medicament with neuroprotector and/or neurotrophic effects on cns and/or pns | Apr 22, 2004 | Abandoned |
Array
(
[id] => 7467360
[patent_doc_number] => 20040198837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Treatment of neuropathic pain or fibromyalgia'
[patent_app_type] => new
[patent_app_number] => 10/828607
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2352
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198837.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828607
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828607 | Treatment of neuropathic pain or fibromyalgia | Apr 20, 2004 | Abandoned |
Array
(
[id] => 7190888
[patent_doc_number] => 20040204444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Combination of organic compounds'
[patent_app_type] => new
[patent_app_number] => 10/826106
[patent_app_country] => US
[patent_app_date] => 2004-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5016
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204444.pdf
[firstpage_image] =>[orig_patent_app_number] => 10826106
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/826106 | Combination of organic compounds | Apr 14, 2004 | Abandoned |
Array
(
[id] => 6959794
[patent_doc_number] => 20050215640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'HMB compositions and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/810762
[patent_app_country] => US
[patent_app_date] => 2004-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 19289
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20050215640.pdf
[firstpage_image] =>[orig_patent_app_number] => 10810762
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/810762 | HMB compositions and uses thereof | Mar 25, 2004 | Abandoned |